ATM and familial pancreatic carcinoma: This includes non-synonymous substitutions and insertion-deletions (indels) and in line with recent reports, underscores the clinical and biological relevance of ATM mutations in a significant subset of human pancreatic cancers (Table 1)3, 5, 14, 16, 17.